Figure 2.

Kaplan–Meier analysis for the cumulative risk of RA among patients with DM and RA, and patients aged 18 years and over on COX-2 inhibitors stratified by metformin with the log-rank test. DM = diabetes mellitus, RA = rheumatoid arthritis